Baxter news from FiercePharma
NewsIMS: Pace of outsourcing accelerating
Drugmakers are pulling out of manufacturing at an unprecedented rate, according to a new report from IMS Health. Four of the top Read more...
Baxter's Robert Parkinson - CEO Pay
Baxter - Robert Parkinson Total Compensation: $17.6M 2007 Revenue: $11.3B2006 Revenue: $10.4BChange: 8.6% Details: Parkinson's $17.6 million haul was driven primarily by strong Read more...
GSK nabs EU approval for pandemic shot
Put GlaxoSmithKline at the head of the list of vaccine-makers able to profit from a potential flu pandemic. The company just got EU go-ahead to market its H5N1 vaccine, Prepandrix, becoming the first Read more...
Leavitt: We'll bar subs-par exporters
U.S. Health and Human Services honcho Mike Leavitt is baring his teeth at Chinese exporters that don't meet certification standards. Saying that regulators simply can't inspect all imported Read more...
Leavitt: We'll bar subs-par exporters
U.S. Health and Human Services honcho Mike Leavitt is baring his teeth at Chinese exporters that don't meet certification standards. Saying that regulators simply can't inspect all imported Read more...
Quaid: Preemption unfair to patients
Dennis Quaid added some star power--and colorful language--to a dry legal debate yesterday. Testifying before Congress, Quaid backed people's right to sue drugmakers, saying that FDA approval Read more...
SPOTLIGHT: Heparin prices double since recalls
Since Baxter recalled virtually all its heparin products on reports of severe reactions and deaths, the price for the blood thinner has doubled. The sole U.S. supplier, APP Pharmaceuticals, says Read more...
Blaming Baxter, China denies heparin guilt
Point fingers at us, we'll point back at you. That's what China appears to be saying about the heparin scandal, claiming that it wasn't the "heparin-like substance" found in batches of the Read more...
Impurities found in Sanofi heparin product
While heparin maker Baxter mulls whether to re-enter the market for that blood thinner, Sanofi-Aventis is announcing that small amounts of an impurity have been found in batches of its heparin Read more...
U.S., China trade blame on heparin
Call it the blame game. The U.S. FDA says it's traced contaminated heparin back to 12 companies in China. Chinese officials, however, claim the problem started in the U.S.--and they plan to visit a Read more...
| Press ReleasesPRESS RELEASE: Baxter and Halozyme Announce Collaboration For Development Of Subcutaneous GAMMAGARD LIQUID Baxter and Halozyme Announce Collaboration For Development Of Subcutaneous GAMMAGARD LIQUID™ Administration using Enhanze™ Technology Development of New Route to Administer GAMMAGARD LIQUID™ Read more... |
Get more Baxter coverage at:
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends